Riverside, Sentara and Bon Secours health systems have all contacted patients who MAY have received drugs purchased from the New England Compounding Center (NECC) in the past few months. The pharmacy is under investigation for a meningitis outbreak linked to the spinal injection of a tainted drug, which has been recalled.
ALL three local health systems emphasize that NO local patients received the alleged tainted drug, but some may have received injections of other drugs from the same company.
In a joint press release, Bon Secours and Sentara, emphasized that "if a patient's procedure occurred more than four weeks ago, it is unlikely there is any cause for concern." It further notes that "it is also unlikely there is a risk of meningitis unless the injection was near or on your spine or joint."
Their release advises a patient to contact their physician immediately if they "received injectable NECC drugs during a recent treatment or surgery and is experiencing symptoms such as fever, nausea, increased pain at incision, redness/drainage around incision." Both have established call centers to help answer questions or concerns: Bon Secours, 757-889-2273 or Sentara, 1-800-736-8272.
Riverside is notifying 100 patients by letter, about half in the Tappahannock region, who received medication from NNEC, according to spokesman Peter Glagola. They will receive follow-up phone calls later in the week. They can also call the 24/7 Riverside Nurse Line, 757-595-6363 for information.
These proactive measures by local health systems have been taken in reaction to the FDA's concern for strong precautions.
For more health news, go to www.dailypress.com/healthCopyright © 2014, The Baltimore Sun